Covered recipient · General Payments record
CHELSEA N WEBB
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$1,590.74
- Reported across 52 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.48 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $115.01 | 1 |
| Acerta Pharma LLC | $45.27 | 3 |
| UCB, Inc. | $30.01 | 1 |
| Viatris Specialty LLC | $19.16 | 1 |
| Vanda Pharmaceuticals Inc. | $19.09 | 1 |
| PFIZER INC. | $18.31 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.83 | 1 |
| Organon LLC | $15.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.64 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206311536 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.14 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206324517 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.49 | 11/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206822788 | CMS |
| Novo Nordisk Inc | $115.01 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188847384 | CMS |
| Organon LLC | $15.80 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237716316 | CMS |
| PFIZER INC. | $18.31 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231682670 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.83 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247549757 | CMS |
| UCB, Inc. | $30.01 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224430631 | CMS |
| Vanda Pharmaceuticals Inc. | $19.09 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233143239 | CMS |
| Viatris Specialty LLC | $19.16 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238493707 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.